What Are Wall Street Analysts’ Target Price for Colgate-Palmolive Company Stock?

Core Insights - Colgate-Palmolive Company is a leading player in oral care, personal care, home cleaning, and pet nutrition, with a market cap of approximately $61.7 billion [1] Stock Performance - The company's shares have underperformed the broader market, declining 18.2% over the past year and 15.8% year-to-date, while the S&P 500 Index has increased by 18.5% and 15.1% respectively [2] - Colgate's stock has also lagged behind the Consumer Staples Select Sector SPDR Fund, which saw a 5.5% dip over the past 52 weeks and a 3.3% decline year-to-date [3] Operational Challenges - The company is facing a challenging operating environment characterized by weak consumer demand, particularly in urban areas where households are financially strained [4] - Colgate is also dealing with inflation in raw materials and packaging, as well as adverse currency and tariff effects that impact flexibility and margins [5] Financial Outlook - For fiscal year 2025, analysts project a 1.7% year-over-year increase in EPS to $3.66, with a history of surpassing earnings estimates in the past four quarters [6] - The stock currently holds a consensus "Moderate Buy" rating, with 10 "Strong Buys," 2 "Moderate Buys," 8 "Holds," and 2 "Strong Sells" among 22 analysts [6] Price Target Insights - JPMorgan recently lowered its price target for Colgate to $88 from $95, maintaining an "Overweight" rating due to weaker category performance and soft organic sales [7] - The mean price target of $88.09 suggests a potential upside of 15.1%, while the highest price target of $100 indicates a possible upside of 30.6% from the current price [7]